Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.48172
Abstract: Key Points Question What is the cost-effectiveness of icosapent ethyl from a US health care perspective for high-risk patients with hypertriglyceridemia despite statin treatment? Findings This economic evaluation including 8179 patients found that icosapent ethyl… read more here.
Keywords: risk patients; icosapent ethyl; cost; high risk ... See more keywords
Cardiovascular Risk Assessment in Patients with Hypertriglyceridemia
Sign Up to like & getrecommendations! Published in 2018 at "Current Cardiology Reports"
DOI: 10.1007/s11886-018-1013-8
Abstract: Purpose of ReviewAssessing the cardiovascular risk associated with hypertriglyceridemia can be challenging due to frequent confounding conditions such as hypertension, diabetes mellitus, and hyperlipidemia. We sought to quantify this risk by examining several meta-analyses as… read more here.
Keywords: risk; risk assessment; patients hypertriglyceridemia; cardiovascular risk ... See more keywords
Effect of omega-3 fatty acids on cardiovascular events in high-risk patients with hypertriglyceridemia in Japan: a 3-year post-marketing surveillance study (OCEAN3 survey)
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2022.2094914
Abstract: ABSTRACT Background Studies on the efficacy of prescription omega-3 polyunsaturated fatty acids to reduce cardiovascular events have produced conflicting results. Research design and methods This 3-year prospective post-marketing surveillance study evaluated the effect of omega-3-acid… read more here.
Keywords: effect; o3aee treated; high risk; treated patients ... See more keywords
Treatment of Hypertriglyceridemia: A Review of Therapies in the Pipeline.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of pharmacy practice"
DOI: 10.1177/08971900211053489
Abstract: BackgroundThe 2018 American College of Cardiology/American Heart Association (ACC/AHA) guidelines and 2021 ACC Expert Consensus Decision Pathway recommend nonpharmacological interventions and initiation of statin therapy for patients with moderate hypertriglyceridemia and addition of fibrates or… read more here.
Keywords: hypertriglyceridemia review; review therapies; pipeline; patients hypertriglyceridemia ... See more keywords
Pharmacokinetics and pharmacodynamics of amiodarone in patients with hypertriglyceridemia: Two case reports.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of clinical pharmacology and therapeutics"
DOI: 10.5414/cp204247
Abstract: BACKGROUND The antiarrhythmic drug amiodarone has noncardiac adverse effects, leading to restrictive therapeutic plasma ranges. Despite the significant positive correlation between triglyceride and amiodarone levels, the effect of fluctuations in amiodarone levels in patients with… read more here.
Keywords: patient; case; amiodarone; amiodarone levels ... See more keywords